Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
Actual shortage: | 250 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2422 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
25 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2022-09-22 | 2022-12-22 | 169957 |
TEVA-ECTOSONE | 0.1% | CREAM | Resolved | 2022-12-22 | 2023-12-14 | 179180 |
TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2023-04-27 | 2023-07-05 | 190689 |
TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2023-06-19 | 2023-07-05 | 195472 |
TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2023-06-19 | 2024-03-18 | 195634 |
TEVA-ECTOSONE | 0.1% | CREAM | Resolved | 2023-06-20 | 2023-07-05 | 195795 |
TEVA-MOMETASONE | 0.1% | OINTMENT | Actual shortage | 2024-02-29 | 2024-05-16 | 220986 |
TEVA-MOMETASONE | 0.1% | OINTMENT | Actual shortage | 2024-04-11 | 2024-04-18 | 224886 |
TEVA-ECTOSONE | 0.1% | LOTION | Actual shortage | 2024-04-25 | 2024-05-03 | 226171 |
TEVA-BUDESONIDE | 0.125MG | SUSPENSION | Resolved | 2020-03-06 | 2020-03-19 | 107964 |
TEVA-BUDESONIDE | 0.125MG | SUSPENSION | Resolved | 2021-06-03 | 2021-10-14 | 140390 |
TEVA-BUDESONIDE | 0.125MG | SUSPENSION | Resolved | 2022-08-18 | 2023-10-06 | 167197 |
TEVA-BUDESONIDE | 0.125MG | SUSPENSION | Resolved | 2023-06-20 | 2023-07-06 | 195815 |
TEVA-BUDESONIDE | 0.125MG | SUSPENSION | Resolved | 2023-11-03 | 2024-01-19 | 209145 |
APRI 21 | 0.15MG 0.03MG | TABLET | Resolved | 2017-05-23 | 2017-09-19 | 10868 |
APRI 28 | 0.15MG 0.03MG | TABLET | Resolved | 2017-05-23 | 2017-09-19 | 10871 |
APRI 28 | 0.15MG 0.03MG | TABLET | Resolved | 2019-08-29 | 2019-10-24 | 92660 |
SEASONALE | 0.15MG 0.03MG | TABLET | Resolved | 2020-10-08 | 2021-02-25 | 126038 |
PORTIA 21 | 0.15MG 0.03MG | TABLET | Resolved | 2020-10-15 | 2020-11-26 | 126530 |
TEVA-CLONIDINE | 0.1MG | TABLET | Resolved | 2020-07-30 | 2020-08-21 | 121503 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
ACT CLOPIDOGREL | Discontinued | 2018-10-19 | 2018-10-19 | 65065 | ||
ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65284 | ||
ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65289 | ||
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81330 | ||
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81337 | ||
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81344 | ||
HYDROCORTISONE SODIUM SUCCINATE INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81347 | ||
TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106136 | ||
TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106139 | ||
RATIO-SALBUTAMOL | Discontinued | 2020-02-13 | 2020-02-13 | 106151 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
LINEZOLID INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106173 | ||
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 | ||
TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION | 0.004% | SOLUTION | Discontinued | 2020-01-21 | 2020-01-21 | 103788 |
TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
RATIO-TAMSULOSIN | 0.4MG | CAPSULE (SUSTAINED-RELEASE) | Discontinued | 2018-10-19 | 2018-10-19 | 64917 |